aim vaccine corporation has always been adhering to the mission of “developing and manufacturing top quality vaccines to safeguard the health of the world” through strict control of vaccine quality. it prides itself on a professional and devoted sales team consisting of more than 100 members with over a decade of pharmaceutical or vaccine sales experience, and a core business leadership team with an average of 12 years of vaccine commercialization experience at transnational pharmaceuticals as well as outstanding achievements in marketing international blockbuster vaccines (including the world’s first hpv, ipv and dtap-ipv-hib vaccines). currently, products available for sale mainly include recombinant hepatitis b vaccine (hansenula polymorpha), rabies vaccine (vero cell) for human use,freeze-dried, hepatitis a vaccine (human diploid cell), inactivated, mumps vaccine, live, haemorrhagic fever with renal syndrome bivalent vaccine (vero cell) and acyw135 meningococcal polysaccharide vaccine (mpsv4).